Stryker beats Q4 estimates, sells spinal implants biz
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Stryker (SYK) PT Raised to $416 at BTIG
January 29, 2025 6:06 AM ESTBTIG analyst Ryan Zimmerman raised the price target on Stryker (NYSE: SYK) to $416.00 (from $394.00) while maintaining a Buy rating.
The analyst comments "We maintain our Buy rating and raise our PT to $416 PT (from $394) following 4Q24 results. SYK delivered strong diversified results in 4Q24 with rev. of $6.436B... More
